Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants

British Journal of Haematology

Volumn 138, Issue 1, 2007, Pages 101-109

  Larghero, Jerome ^a   Rocha, Vanderson ^a   Porcher, Raphael ^a   Filion, Alain ^a   Ternaux, Brigitte ^a   Lacassagne, Marie Noelle ^a   Robin, Marie ^a   Peffault De Latour, Regis ^a   Devergie, Agnes ^a   Biscay, Nicole ^a   Ribaud, Patricia ^a   Benbunan, Marc ^a   Gluckman, Eliane ^a   Marolleau, Jean Pierre ^a   Socié, Gerard ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Bone marrow transplantation; Graft versus host disease; Haematopoietic recovery; Natural killer cells

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL POPULATION; CHRONIC GRAFT VERSUS HOST DISEASE; FEMALE; HLA SYSTEM; HUMAN; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; SURVIVAL; VIRUS INFECTION;

ADULT; BACTERIAL INFECTIONS; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; MALE; MYCOSES; NEUTROPHILS; PROPORTIONAL HAZARDS MODELS; TRANSPLANTATION, ISOGENEIC; VIRUS DISEASES;

EID: 34250026971     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06623.x     Document Type: Article

References (41)

1. Abrahamsen, I.W., Somme, S., Heldal, D., Egeland, T., Kvale, D. Tjonnfjord, G.E. (2005) Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease. Haematologica, 90, 86 93.
2. Aguila, H.L. Weissman, I.L. (1996) Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood, 87, 1225 1231.
3. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee 1992) Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine, 20, 864 874.
4. Asai, O., Longo, D.L., Tian, Z.G., Hornung, R.L., Taub, D.D., Ruscetti, F.W. Murphy, W.J. (1998) Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. Journal of Clinical Investigation, 101, 1835 1842.
5. Barrett, A.J., Ringden, O., Zhang, M.J., Bashey, A., Cahn, J.Y., Cairo, M.S., Gale, R.P., Gratwohl, A., Locatelli, F., Martino, R., Schultz, K.R. Tiberghien, P. (2000) Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood, 95, 3323 3327.
6. Bensinger, W.I., Martin, P.J., Storer, B., Clift, R., Forman, S.J., Negrin, R., Kashyap, A., Flowers, M.E., Lilleby, K., Chauncey, T.R., Storb, R. Appelbaum, F.R. (2001) Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. New England Journal of Medicine, 344, 175 181.
7. Bittencourt, H., Rocha, V., Chevret, S., Socie, G., Esperou, H., Devergie, A., Dal Cortivo, L., Marolleau, J.P., Garnier, F., Ribaud, P. Gluckman, E. (2002) Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood, 99, 2726 2733.
8. Blaise, D., Kuentz, M., Fortanier, C., Bourhis, J.H., Milpied, N., Sutton, L., Jouet, J.P., Attal, M., Bordigoni, P., Cahn, J.Y., Boiron, J.M., Schuller, M.P., Moatti, J.P. Michallet, M. (2000) Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. Journal of Clinical Oncology, 18, 537 546.
9. Couban, S., Simpson, D.R., Barnett, M.J., Bredeson, C., Hubesch, L., Howson-Jan, K., Shore, T.B., Walker, I.R., Browett, P., Messner, H.A., Panzarella, T. Lipton, J.H. Canadian Bone Marrow Transplant Group (2002) A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood, 100, 1525 1531.
10. Cutler, C., Giri, S., Jeyapalan, S., Paniagua, D., Viswanathan, A. Antin, J.H. (2001) Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. Journal of Clinical Oncology, 19, 3685 3691.
11. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. Thomas, E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295 304.
12. Gratwohl, A., Baldomero, H., Frauendorfer, K. Urbano-Ispizua, A. Joint Accreditation Committee, International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation 2006) EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplantation, 37, 1069 1085.
13. Guardiola, P., Runde, V., Bacigalupo, A., Ruutu, T., Locatelli, F., Boogaerts, M.A., Pagliuca, A., Cornelissen, J.J., Schouten, H.C., Carreras, E., Finke, J., van Biezen, A., Brand, R., Niederwieser, D., Gluckman, E., de Witte, T.M. Subcommittee for Myelodysplastic Syndromes of the Chronic Leukaemia Working Group of the European Blood and Marrow Transplantation Group 2002) Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes. Blood, 99, 4370 4378.
14. Heldal, D., Tjonnfjord, G., Brinch, L., Albrechtsen, D., Egeland, T., Steen, R., Solheim, B.G. Evensen, S.A. (2000) A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplantation, 25, 1129 1136.
15. Horan, J.T., Liesveld, J.L., Fernandez, I.D., Lyman, G.H., Phillips, G.L., Lerner, N.B. Fisher, S.G. (2003) Survival after HLA-identical allogeneic peripheral blood stem cell and bone marrow transplantation for hematologic malignancies: meta-analysis of randomized controlled trials. Bone Marrow Transplantation, 32, 293 298.
16. Huang, Y., Rezzoug, F., Chilton, P.M., Grimes, H.L., Cramer, D.E. Ildstad, S.T. (2004) Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment. Blood, 104, 873 880.
17. Huang, Y., Rezzoug, F., Xu, H., Chilton, P.M., Schanie, C.L., Fugier-Vivier, I. Ildstad, S.T. (2005) NK cells play a critical role in the regulation of class I-deficient hematopoietic stem cell engraftment: evidence for NK tolerance correlates with receptor editing. Journal of Immunology, 175, 3753 3761.
18. Kim, DH., Sohn, S.K., Lee, N.Y., Baek, J.H., Kim, J.G., Won, D.I., Suh, J.S., Lee, K.B. Shin, I.H. (2005) Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. European Journal of Haematology, 75, 299 308.
19. Ljungman, P. Griffiths, P. (1993) Definitions of cytomegalovirus infection and disease. In : Proceedings of the Fourth International Cytomegalovirus Workshop: Multidisciplinary Approach to Understanding Cytomegalovirus Disease (ed. by S. Michelson S.A. Plotkin pp. 233 237. Elsevier Science Publishers BV, Paris, France.
20. Lortholary, O., Ascioglu, S., Moreau, P., Herbrecht, R., Marinus, A., Casassus, P., DePauw, B. Denning, D.W. (2000) Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer. Clinical Infectious Diseases, 30, 41 46.
21. Lossos, I.S., Breuer, R., Or, R., Strauss, N., Elishoov, H., Naparstek, E., Aker, M., Nagler, A., Moses, A.E. Shapiro, M. (1995) Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation, 60, 672 678.
22. Mavroudis, D., Read, E., Cottler-Fox, M., Couriel, D., Molldrem, J., Carter, C., Yu, M., Dunbar, C. Barrett, J. (1996) CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood, 88, 3223 3229.
23. Mehta, J., Powles, R., Singhal, S., Horton, C., Middleton, G., Eisen, T., Meller, S., Pinkerton, C.R. Treleaven, J. (1997) Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts. Bone Marrow Transplantation, 19, 349 355.
24. Morariu-Zamfir, R., Rocha, V., Devergie, A., Socie, G., Ribaud, P., Esperou, H., Parquet, N., Guardiola, P., Dal Cortivo, L., Bittencourt, H., Garnier, F., Traineau, R., Marolleau, J.P., Chevret, S. Gluckman, E. (2001) Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia. Bone Marrow Transplantation, 27, 575 580.
25. Niederwieser, D., Pepe, M., Storb, R., Loughran, Jr., T.P. Longton, G. (1988) Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. British Journal of Haematology, 69, 23 28.
26. Ohlen, C., Kling, G., Hoglund, P., Hansson, M., Scangos, G., Bieberich, C., Jay, G. Karre, K. (1989) Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science, 246, 666 668.
27. Powles, R., Mehta, J., Kulkarni, S., Treleaven, J., Millar, B., Marsden, J., Shepherd, V., Rowland, A., Sirohi, B., Tait, D., Horton, C., Long, S. Singhal, S. (2000) Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet, 355, 1231 1237.
28. Raulet, D.H., Vance, R.E. McMahon, C.W. (2001) Regulation of the natural killer cell receptor repertoire. Annual Review of Immunology, 19, 291 330.
29. Rocha, V., Carmagnat, M.V., Chevret, S., Flinois, O., Bittencourt, H., Esperou, H., Garnier, F., Ribaud, P., Devergie, A., Socie, G., Dal'Cortivo, L., Marolleau, J.P., Charron, D., Gluckman, E. Rabian, C. (2001) Influence of bone marrow graft lymphocyte subset on the outcome of HLA-identical sibling transplants. Experimental Hematology, 29, 1347 1352.
30. Rocha, V., Labopin, M., Gluckman, E., Powles, R., Arcese, W., Bacigalupo, A., Reiffers, J., Iriondo, A., Ringden, O., Ruutu, T., Frassoni, F. Acute Leukemia Working Party of the European Blood and Marrow Transplant Registry 2002) Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. Journal of Clinical Oncology, 20, 4324 4330.
31. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W.D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M.F. Velardi, A. (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science, 295, 2097 2100.
32. Russell, J.A., Larratt, L., Brown, C., Turner, A.R., Chaudhry, A., Booth, K., Woodman, R.C., Wolff, J., Valentine, K., Stewart, D., Ruether, J.D., Ruether, B.A., Klassen, J., Jones, A.R., Gyonyor, E., Egeler, M., Dunsmore, J., Desai, S., Coppes, M.J., Bowen, T., Anderson, R. Poon, M.C. (1999) Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome. Bone Marrow Transplantation, 24, 1177 1183.
33. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204 217.
34. Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M. Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 4226 4235.
35. Singhal, S., Powles, R., Treleaven, J., Kulkarni, S., Sirohi, B., Horton, C., Millar, B., Shepherd, V., Tait, D., Saso, R., Rowland, A., Long, S. Mehta, J. (2000) A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106/kg CD34+ cells be considered the minimum threshold Bone Marrow Transplantation, 26, 489 496.
36. Storb, R., Prentice, R.L. Thomas, E.D. (1977) Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. New England Journal of Medicine, 296, 61 66.
37. Sullivan, K.M., Shulman, H.M., Storb, R., Weiden, P.L., Witherspoon, R.P., McDonald, G.B., Schubert, M.M., Atkinson, K. Thomas, E.D. (1981) Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood, 57, 267 276.
38. Theilgaard-Monch, K., Raaschou-Jensen, K., Palm, H., Schjodt, K., Heilmann, C., Vindelov, L., Jacobsen, N. Dickmeiss, E. (2001) Flow cytometric assessment of lymphocytes subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplantation, 28, 1073 1082.
39. Vigorito, A.C., Azevedo, W.M., Marques, J.F., Azevedo, A.M., Eid, K.A., Aranha, F.J., Lorand-Metze, I., Oliveira, G.B., Correa, M.E., Reis, A.R., Miranda, E.C. de Souza, C.A. (1998) A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplantation, 22, 1145 1151.
40. Voutsadakis, I.A. (2003) NK cells in allogeneic bone marrow transplantation. Cancer Immunology and Immunotherapy, 52, 525 534.
41. Yamasaki, S., Henzan, H., Ohno, Y., Yamanaka, T., Iino, T., Itou, Y., Kuroiwa, M., Maeda, M., Kawano, N., Kinukawa, N., Miyamoto, T., Nagafuji, K., Shimoda, K., Inaba, S., Hayashi, S., Taniguchi, S., Shibuya, T., Gondo, H., Otsuka, T., Harada, M. Fukuoka Blood and Marrow Transplantation Group (2003) Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors. Bone Marrow Transplantation, 32, 505 510.